Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/31/2025

Antiemetic Medications for Labor-Related Nausea and Vomiting

  • The American College of Obstetricians and Gynecologists recommends ondansetron or metoclopramide as first-line antiemetic medications for pregnant women in active labor experiencing vomiting, with ondansetron showing superior efficacy for severe vomiting 1, 2, 3
  • Ondansetron is effective for intraoperative and postoperative nausea/vomiting during cesarean delivery, as demonstrated by the American Journal of Obstetrics and Gynecology 1, 2, 3
  • Metoclopramide is considered safe in pregnancy, with large cohort data showing no increased congenital malformations, according to the Annals of Oncology and the American College of Obstetricians and Gynecologists 4, 5

Combination Therapy for Refractory Cases

  • A multimodal approach is strongly recommended for optimal control, combining a 5-HT3 antagonist (ondansetron) with either dexamethasone or droperidol for significantly better efficacy than single agents, as suggested by the American College of Obstetricians and Gynecologists 1, 2
  • Combination regimens reduce both intraoperative and postoperative nausea/vomiting more effectively, according to the American College of Obstetricians and Gynecologists 1

Important Clinical Considerations

  • Maternal hypotension from regional anesthesia is the most common cause of nausea/vomiting during labor/delivery, and fluid preloading with crystalloid or colloid reduces hypotension and associated nausea/vomiting, as recommended by the American College of Obstetricians and Gynecologists 1, 2
  • IV ephedrine or phenylephrine administration prevents hypotension-related symptoms, and lower limb compression (bandages, stockings, or inflatable boots) also reduces anesthesia-related hypotension, according to the American College of Obstetricians and Gynecologists 1, 2
  • Anticholinergics (scopolamine) are more effective for postoperative rather than intraoperative nausea, and supplemental oxygen, IV fluids alone, acupressure/acupuncture are not effective for reducing intraoperative nausea or vomiting, as stated by the American College of Obstetricians and Gynecologists 1, 2

Metoclopramide Use in Labor

Primary Recommendation

  • The American Society of Anesthesiologists guidelines support metoclopramide's efficacy in reducing peripartum nausea and vomiting in pregnant women, with a strong recommendation and moderate evidence 6, 7

Evidence Supporting Use in Labor

Efficacy During Labor and Delivery

  • The American Society of Anesthesiologists guidelines specifically support metoclopramide's efficacy in reducing peripartum nausea and vomiting in pregnant women, with extensive safety data and guideline support from the American Society of Anesthesiologists and ACOG 6, 7
  • For cesarean delivery, dopamine antagonists (including metoclopramide and droperidol) are effective for reducing intraoperative nausea and vomiting, with a strong recommendation and moderate evidence 8

Optimal Treatment Strategy

  • For optimal nausea and vomiting control during labor, consider a multimodal approach combining metoclopramide with other interventions, such as addressing maternal hypotension with fluid preloading and administering IV ephedrine or phenylephrine, with a strong recommendation and moderate evidence 8
  • Consider lower limb compression (bandages, stockings, or inflatable boots) to reduce anesthesia-related hypotension, with a strong recommendation and moderate evidence 8

Combination Antiemetics

  • For refractory cases or cesarean delivery, combine a 5-HT3 antagonist (ondansetron) with either metoclopramide, dexamethasone, or droperidol for significantly better efficacy than single agents, with a strong recommendation and moderate evidence 8

Practical Implementation

  • Administer metoclopramide 10 mg IV when a laboring patient develops nausea or vomiting, after ensuring adequate hydration and blood pressure management, with a strong recommendation and moderate evidence 6, 8